Sponsored Feature

Today's Sponsored Feature is part of your subscription to the daily FDLI SmartBrief. This feature, produced by SmartBrief and a select group of sponsors, highlights issues, products and services of interest to the food and drug industry. It also allows for continued free delivery of FDLI SmartBrief. Thank you for your interest.

— The FDLI SmartBrief Team


A Tool To Meet The Demands Of Medical-Based Claims

While software tools to manage general case information are widely used in law firms, a similar tool to manage the medical information and assist in the creation of medical chronologies and other summary work products has been needed. The innovative SmartCase application unveiled by Litigation Management, Inc. fills this need.

Read full article

Attorneys, paralegals and legal nurse consultants now have a do-it-yourself tool to manage medical records, create detailed chronologies and deliver work products electronically to clients.
Take a Tour.

A partner company of Litigation Management, Inc. (LMI), SmartCase offers a Web-based medical information management option to law firms, legal nurse consultants and paralegals. This Software as a Service (SaaS) application, the first of its kind in the medical information management industry, helps subscribers improve their productivity in reviewing and summarizing medical records. Learn more.

Offering:
SmartCaseone — For independent service providers

Offering:
SmartCasepro — For law firms and legal departments

Related Article:
The McKinsey Quarterly: Delivering Software as a Service

Application Overview:
Technology for the Legal Professional

Testimonial:
SmartCase Helps Legal Nurse Consultant Meet Tight Deadline

Test Drive:
Free 14-Day Trial with code FDLI07



The Evolution of Medical Information Management

As technology has evolved, so has the practice of medical information management in litigation. Attorneys, paralegals and legal nurse consultants working on the medical aspects of individual cases can now take advantage of functionality originally developed to support large-scale litigation.

Read full article

IBM creates 3-D medical records technology

IBM's Anatomic and Symbolic Mapper Engine allows physicians to access medical records with a 3-D avatar, creating a visual representation of the human body and linking medical data to corresponding parts of the anatomy. The lead researcher for the technology says the engine will reduce physicians' need to wade through large volumes of paperwork. Computing (U.K.) (9/25)

Pfizer liability suit to go to Supreme Court

The Supreme Court has taken the product liability suit filed by a group of Michigan plaintiffs against Pfizer's Warner-Lambert unit, a case that would establish whether federal regulation of pharmaceuticals takes precedence over state law. A ruling is expected before the current term of the court ends in June. Forbes/Associated Press (9/25)

Study: Mercury-based vaccines don't hurt youth brain function

Exposure to the preservative thimerosal in vaccines before and after birth did not hinder any of 42 neuropsychological functions tested, a result that researchers called unsurprising but "reassuring." The study looked at more than 1,000 children ages 7 to 10, and did not look at autism. Some experts called the results biased and lobbied for more tests. Scientific American (9/26)

House passes microwave popcorn chemical bill

The U.S. House passed a bill late last month to impose limits on exposure to diacetyl, a chemical linked to bronchiolitis obliterans. Diacetyl is used mainly in flavor-manufacturing plants and microwave-popcorn facilities. ConAgra Foods and Weaver Popcorn have recently said they would stop using the chemical. The Seattle Times (9/27)

Bush signs drug-safety bill

President George W. Bush signed the drug safety bill into law in September, certifying expanded FDA authority on prescription drugs. Aside from giving the FDA power to require further study on drugs to ensure product safety, the new law also authenticates a five-year extension of programs that collect fees from drugmakers and medical device manufacturers to help fund FDA product reviews. Google/Associated Press (9/27)

 

What is this? A Sponsored Feature is an advertorial that includes valuable content provided by the sponsor and editorial materials from SmartBrief's archives. This Sponsored Feature does not represent an endorsement by Food and Drug Law Institute or SmartBrief, Inc. of the products and services offered. If you unsubscribe from this Sponsored Feature, you will not be unsubscribing from all other editions of the FDLI SmartBrief.
Subscriber Tools:
Sign up for FDLI SmartBrief | Send Feedback | Unsubscribe from FDLI SmartBrief Sponsored Features
Advertising with SmartBrief: Sales Account Director: Danielle Mulligan 202-737-5500 x232
Mailing Address: SmartBrief, Inc.
1100 H ST NW, Suite 1000
Washington, DC 20005
© 1999-2006 SmartBrief, Inc. Legal information.